
    
      In this trial, 20 patients with lung cancer, 10 patients with asthma and 10 patients with
      interstitial lung disease who have to undergo bronchocospy for medical reasons are enrolled.
      In each patient, bronchoalveolar lavage is performed to assess PD1-lymphocytes.
    
  